Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Measurement Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study

Adelson JD, Bourne RRA, Briant PS, et al. Elsevier BV. The Lancet Global Health. 2021; 9 (2) : e144-e160.
Download PDF
Publication

The effectiveness of training strategies to improve healthcare provider practices in low-income and middle-income countries

Rowe AK, Rowe S, Peters D, et al. BMJ. BMJ Global Health. 2021; 6 (1) : e003229.
Download PDF
Publication

Mycetoma and the Community Dermatology Program, Mexico

Roberto E, Guadalupe C, Guadalupe E, et al. Oxford University Press (OUP). Transactions of The Royal Society of Tropical Medicine and Hygiene. 2021;
Download PDF
Publication

MycetOS – An open research model discover new drugs to treat one of the most neglected disease – Mycetoma

Lim W, Eadie K, Konings M, et al. Elsevier BV. International Journal of Infectious Diseases. 2020;
Download PDF
Publication

Negative pressure wound therapy for skin necrosis prevention after snakebite in the emergency department

Kim KJ, Min JH, Yoo I, et al. Ovid Technologies (Wolters Kluwer Health). Medicine. 2021; 100 (3) : e24290.
Download PDF
Publication

Preparing for a COVID-19 resurgence in the WHO African region

Impouma B, Mboussou F, Kasolo F, et al. Elsevier BV. The Lancet. 2021;
Download PDF
Publication

Transitioning from donor aid for health: perspectives of national stakeholders in Ghana

Mao W, Kennedy McDade K, Huffstetler HE, et al. BMJ. BMJ Global Health. 2021; 6 (1) : e003896.
Download PDF
Publication

Medicine donation programmes supporting the global drive to end the burden of neglected tropical diseases

Bradley M, Taylor R, Jacobson J, et al. Oxford University Press (OUP). Transactions of The Royal Society of Tropical Medicine and Hygiene. 2021;
Download PDF
Publication

Addressing the disconnect between trial intention and design

Howie A, Taljaard M, Moon PM, et al. Elsevier BV. The Lancet Global Health. 2021;
Download PDF
Publication

Leprosy perceptions and knowledge in endemic districts in India and Indonesia: Differences and commonalities.

van 't Noordende A, Lisam S, Ruthindartri P, et al. PLoS neglected tropical diseases. 2021; 15 (1) : e0009031.
Download PDF

Pagination

  • Previous page ‹ ‹ Previous
  • …
  • Page 466
  • Page 467
  • Page 468
  • Page 469
  • Current page 470
  • Page 471
  • Page 472
  • Page 473
  • Page 474
  • …
  • Next page Next › ›
  • Last page Last » »
Subscribe to

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2026 InfoNTD